Literature DB >> 24398587

Pathophysiological mechanisms of catecholamine and cocaine-mediated cardiotoxicity.

Lucas Liaudet1, Belinda Calderari, Pal Pacher.   

Abstract

Overactivation of the sympatho-adrenergic system is an essential mechanism providing short-term adaptation to the stressful conditions of critical illnesses. In the same way, the administration of exogenous catecholamines is mandatory to support the failing circulation in acutely ill patients. In contrast to these short-term benefits, prolonged adrenergic stress is detrimental to the cardiovascular system by initiating a series of adverse effects triggering significant cardiotoxicity, whose pathophysiological mechanisms are complex and only partially elucidated. In addition to the development of myocardial oxygen supply/demand imbalance induced by the sustained activation of adrenergic receptors, catecholamines can damage cardiomyocytes by fostering mitochondrial dysfunction, via two main mechanisms. The first one is calcium overload, consecutive to β-adrenergic receptor-mediated activation of protein kinase A and subsequent phosphorylation of multiple Ca(2+)-cycling proteins. The second one is oxidative stress, primarily related to the transformation of catecholamines into "aminochromes," which undergo redox cycling in mitochondria to generate copious amounts of oxygen-derived free radicals. In turn, calcium overload and oxidative stress promote mitochondrial permeability transition and cardiomyocyte cell death, both via the apoptotic and necrotic pathways. Comparable mechanisms of myocardial toxicity, including marked oxidative stress and mitochondrial dysfunction, have been reported with the use of cocaine, a common recreational drug with potent sympathomimetic activity. The aim of the current review is to present in detail the pathophysiological processes underlying the development of catecholamine and cocaine-induced cardiomyopathy, as such conditions may be frequently encountered in the clinical practice of cardiologists and ICU specialists.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24398587     DOI: 10.1007/s10741-014-9418-y

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  87 in total

1.  Cardiovascular complications of cocaine use.

Authors:  R A Lange; L D Hillis
Journal:  N Engl J Med       Date:  2001-08-02       Impact factor: 91.245

Review 2.  Vasoactive drugs in circulatory shock.

Authors:  Steven M Hollenberg
Journal:  Am J Respir Crit Care Med       Date:  2010-11-19       Impact factor: 21.405

Review 3.  β-Adrenergic regulation of the cardiac Na+-K+ ATPase mediated by oxidative signaling.

Authors:  Keyvan Karimi Galougahi; Chia-Chi Liu; Henning Bundgaard; Helge H Rasmussen
Journal:  Trends Cardiovasc Med       Date:  2012-05       Impact factor: 6.677

4.  Reactive oxygen species mediate alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes.

Authors:  J K Amin; L Xiao; D R Pimental; P J Pagano; K Singh; D B Sawyer; W S Colucci
Journal:  J Mol Cell Cardiol       Date:  2001-01       Impact factor: 5.000

5.  Key role of Ca in the production of noncoronarogenic myocardial necroses.

Authors:  A Fleckenstein; J Kanke; H J Döring; O Leder
Journal:  Recent Adv Stud Cardiac Struct Metab       Date:  1975

Review 6.  Mitochondria play a central role in nonischemic cardiomyocyte necrosis: common to acute and chronic stressor states.

Authors:  M Usman Khan; Yaser Cheema; Atta U Shahbaz; Robert A Ahokas; Yao Sun; Ivan C Gerling; Syamal K Bhattacharya; Karl T Weber
Journal:  Pflugers Arch       Date:  2012-02-11       Impact factor: 3.657

Review 7.  Acute reversal of pheochromocytoma-induced catecholamine cardiomyopathy.

Authors:  A S Nanda; A Feldman; C S Liang
Journal:  Clin Cardiol       Date:  1995-07       Impact factor: 2.882

Review 8.  Adrenergic nervous system in heart failure: pathophysiology and therapy.

Authors:  Anastasios Lymperopoulos; Giuseppe Rengo; Walter J Koch
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

9.  EXPERIMENTAL MYOCARDITIS; A STUDY OF THE HISTOLOGICAL CHANGES FOLLOWING INTRAVENOUS INJECTIONS OF ADRENALIN.

Authors:  R M Pearce
Journal:  J Exp Med       Date:  1906-05-25       Impact factor: 14.307

10.  Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes.

Authors:  D B Zorov; C R Filburn; L O Klotz; J L Zweier; S J Sollott
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

View more
  36 in total

1.  Genetic and toxicologic investigation of Sudden Cardiac Death in a patient with Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) under cocaine and alcohol effects.

Authors:  Francesca Cittadini; Nadia De Giovanni; Mireia Alcalde; Sara Partemi; Arnaldo Carbone; Oscar Campuzano; Ramon Brugada; Antonio Oliva
Journal:  Int J Legal Med       Date:  2014-11-16       Impact factor: 2.686

2.  Cardioprotective effects of iron chelator HAPI and ROS-activated boronate prochelator BHAPI against catecholamine-induced oxidative cellular injury.

Authors:  Pavlína Hašková; Hana Jansová; Jan Bureš; Miloslav Macháček; Anna Jirkovská; Katherine J Franz; Petra Kovaříková; Tomáš Šimůnek
Journal:  Toxicology       Date:  2016-10-12       Impact factor: 4.221

3.  Evidence for cardiotoxicity associated with sertraline in rats.

Authors:  Sinem Ilgin; Volkan Kilic; Merve Baysal; Gozde Aydogan-Kilic; Seyda Ucarcan; Begum Dermenci; Ozlem Atli
Journal:  Toxicol Res (Camb)       Date:  2018-04-06       Impact factor: 3.524

4.  Improvement in clinical outcomes of patients with heart failure and active cocaine use after β-blocker therapy.

Authors:  Persio D Lopez; Adedoyin Akinlonu; Tuoyo O Mene-Afejuku; Carissa Dumancas; Mohammed Saeed; Eder H Cativo; Ferdinand Visco; Savi Mushiyev; Gerald Pekler
Journal:  Clin Cardiol       Date:  2018-04-17       Impact factor: 2.882

Review 5.  [Catecholamines: pro and contra].

Authors:  R Riessen; O Tschritter; U Janssens; M Haap
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-03-25       Impact factor: 0.840

Review 6.  Myocardial ischemia and coronary disease in heart failure.

Authors:  Beniamino R Pagliaro; Francesco Cannata; Giulio G Stefanini; Leonardo Bolognese
Journal:  Heart Fail Rev       Date:  2020-01       Impact factor: 4.214

Review 7.  Stimulant Drugs of Abuse and Cardiac Arrhythmias.

Authors:  Paari Dominic; Javaria Ahmad; Hajra Awwab; Md Shenuarin Bhuiyan; Christopher G Kevil; Nicholas E Goeders; Kevin S Murnane; James C Patterson; Kristin E Sandau; Rakesh Gopinathannair; Brian Olshansky
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-12-28

Review 8.  Drug-induced mitochondrial dysfunction and cardiotoxicity.

Authors:  Zoltán V Varga; Peter Ferdinandy; Lucas Liaudet; Pál Pacher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-18       Impact factor: 4.733

9.  Cocaine Exposure Increases Blood Pressure and Aortic Stiffness via the miR-30c-5p-Malic Enzyme 1-Reactive Oxygen Species Pathway.

Authors:  Wei Zhu; Huilan Wang; Jianqin Wei; Gregory C Sartor; Michelle Meiqi Bao; Clay T Pierce; Claes R Wahlestedt; Derek M Dykxhoorn; Chunming Dong
Journal:  Hypertension       Date:  2018-02-26       Impact factor: 10.190

10.  The IgG3 subclass of β1-adrenergic receptor autoantibodies is an endogenous biaser of β1AR signaling.

Authors:  Maradumane L Mohan; Yuji Nagatomo; Prasenjit Prasad Saha; Sromona D Mukherjee; Timothy Engelman; Rommel Morales; Stanley L Hazen; W H Wilson Tang; Sathyamangla V Naga Prasad
Journal:  Mol Biol Cell       Date:  2021-02-03       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.